期刊文献+

23价肺炎球菌多糖疫苗安全性及免疫原性现场考察 被引量:2

Field Trial of Safety and Immunogenicity of 23-valent Penumococcal Polysaccharide Vaccine
暂未订购
导出
摘要 对 140名 5 5~ 70岁老人肌肉注射 2 3价肺炎球菌多糖疫苗 ,剂量为 5 75 μg 0 .5ml。于注射后观察反应 ,并于接种前及接种后 1个月分别采血 ,用ELISA改良法检测 2 3种抗体水平。疫苗接种后全身反应轻微 ,接种 6~ 8h和 2 4h内分别有 2 8人 (2 0 .0 0 % )和 38人 (2 7.14% )发生不同程度局部红肿 ,分别有 5 8人 (41.42 % )和 41人 (2 9.2 8% )局部疼痛。 48h后 ,上述局部反应明显减轻 ,72h后全部症状消失。检测 10 0名被接种者抗体滴度 ,均有良好的免疫应答 ,总抗体的几何平均滴度 (GMT)增加 2 .4倍 ,除 3型外 ,各型免前免后滴度差异均有非常显著意义 ,表明疫苗免疫原性较好。 The adverse reactions was observed in 140 elderly person (aged 55 70 years) 6-8,24 and 72h after being intramuscularly injected with 23-valent(575μg/0.5ml)penumococcal polysaccharidevaccine.The systemic reaction was mild. Local red and sswelling at different degrees were observed in 28(20.00%) and 38 cases(27.14%) within 6-8 and 24h respectively, while local pain were observed in 58(41.42%) and 41(29.28%) cases respectively. However, all the reactions were abated 48h and disappeared 72h after immunization. Blood samples were collected from 100 of the 140 person before and 1 month after immunization and detected for the titers of 23 kinds of antibodies by improved ELISA.The result showed that the GMT of total antibody of them increased by 2.4 folds. Significant differences were observed in the titers of all the antibodies except for type 3 before and after immunization. It showed good immunogenicity of the vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 1999年第2期121-123,共3页 Chinese Journal of Biologicals
关键词 肺炎球菌 多糖疫苗 安全性 免疫原性 Penumococcal polysaccharide vaccine Safety Immunogenicity
  • 相关文献

参考文献2

  • 1Lee H J,Vaccine,1995年,13卷,1 6期,1533页
  • 2展明霞,国外医学预防、诊断、治疗用生物制品分册,1986年,9卷,2期,60页

同被引文献21

  • 1徐英,董碧蓉.老年人群接种23价肺炎球菌疫苗的不良反应观察[J].临床内科杂志,2004,21(7):491-492. 被引量:10
  • 2董景五.疾病和有关健康问题的国际统计分类(第10次修订本,第1卷)[M],2版,北京:人民卫生出版社,2006.
  • 3舍曼.富兰德.卫生经济学[M].3版.北京:中国人民大学出版社,2007:39.
  • 4北京市统计局,国家统计局北京调查总队.北京统计年鉴[M].北京:中国统计出版社,2007.
  • 5Leophonte P,Neukirch F. Anti-pneurnococcal vaccination: role and indications in the prevention of community acquired infections of the lower respiratory tract[J]. Med Mal Infect,2001,31 (4) : 181 - 194.
  • 6Jachson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults[J]. N Eng J Med, 2003,348(18) :1747 - 1755.
  • 7Sisk JE, Moskowitz A J, Whang W, et al. Cost-effectiveness of vaccintion against pneumoeoccai bacteremia among elderly people[ J]. JAMA, 1997,278 (16) : 1333 - 1339.
  • 8Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large- scale intervention with influenza and 23-valent pneumococcal vaccine in adults aged 65 years or older:a prospective study[ J]. Lancet,2001,357 : 1008 - 1011.
  • 9程晓明.卫生经济学[M].北京:人民卫生出版社,2005.11.
  • 10李立明.流行病学[M].6版.北京:人民卫生出版社,2007:338-339.

引证文献2

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部